Recently published (27 May 2021) in Nature Communications, a highly respected peer-reviewed scientific journal: Human stem cells harboring a suicide gene improve the safety and standardisation of neural transplants i...
"Hiding therapeutic cells (hypoimmunogenic or immune cloaked) from the immune system is intrinsically risky. Therefore, the development and use of these cells have to contain a system that replaces the missing tumour sur...
Licenses aim to accelerate drug discovery leading to development of new therapies PanCELLa agreement marks MilliporeSigma’s first CRISPR license for bioproduction “MilliporeSigma’s latest CRISPR licenses are th...
The inventors of panCELLa's exclusive induced Allogeneic Cell Tolerance have recently published a letter in CellStemCell. This letter is in response to Bryan J. González, et. all's "How Safe Are Universal Pluripotent...
panCELLa’s Dr. Nagy recently attended the Alliance for Regenerative Medicine’s inaugural Meeting on the Med (April 23rd to April 25th 2019) where he spoke about how panCELLa addresses the two main concerns of cell th...
panCELLa’s President and CSO, Dr. Andras Nagy, is co-author of a recent paper that appears in CELL detailing the finding of “pluripotent founder cells” (PFCs) or “Kingpin” cells in a study headed by Dr. Mio Nak...
Toronto, ON, April 15, 2019 – panCELLa Inc announced today that Dr. Andras Nagy, President & CSO, will present at the inaugural Cell & Gene Meeting on the Mediterranean to be held April 23-25 in Barcelona, Spai...
panCELLa’s President and CSO, Dr. Andras Nagy attended the COA 2018 in Xiamen, China. Dr. Nagy gave a talk on FailSafe and iACT Stealth Cells at The 13th Annual Congress of Chinese Orthopedic Association 2018. Follo...
A recent article from the Medicine by Design highlights two technologies or platforms stemming from Dr. Nagy's lab at the Lunenfeld-Tanenbaum Research Institute at the Sinai Health System. In addition to being a senio...
Dr. Andras Nagy, panCELLa's President and CSO, will be speaking Friday October 19th at the 3rd International Conference on “Stem Cells, Development and Cancer.” . His talk at 9:00am will be on “Engineering a Saf...